일개 대학병원 중환자실에 입원한 소아 환자에서 발생한 원내감염의 양상

Pattern of Hospital-Associated Infections in Children Admitted in the Intensive Care Unit of a University Hospital

  • 김수남 (가천대학교 의학전문대학원 소아과학교실) ;
  • 원종복 (가천대학교 의학전문대학원 소아과학교실) ;
  • 조혜정 (가천대학교 의학전문대학원 소아과학교실) ;
  • 은병욱 (가천대학교 의학전문대학원 소아과학교실) ;
  • 심소연 (가천대학교 의학전문대학원 소아과학교실) ;
  • 최덕영 (가천대학교 의학전문대학원 소아과학교실) ;
  • 선용한 (가천대학교 의학전문대학원 소아과학교실) ;
  • 조강호 (가천대학교 의학전문대학원 소아과학교실) ;
  • 손동우 (가천대학교 의학전문대학원 소아과학교실) ;
  • 차한 (가천대학교 의학전문대학원 소아과학교실) ;
  • 전인상 (가천대학교 의학전문대학원 소아과학교실)
  • Kim, Su Nam (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Won, Chong Bock (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Cho, Hye Jung (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Eun, Byung Wook (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Sim, So Yeon (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Choi, Deok Young (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Sun, Yong Han (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Cho, Kang Ho (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Son, Dong Woo (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Tchah, Hann (Department of Pediatrics, Graduate School of Medicine, Gachon University) ;
  • Jeon, In Sang (Department of Pediatrics, Graduate School of Medicine, Gachon University)
  • 투고 : 2011.09.14
  • 심사 : 2011.10.04
  • 발행 : 2011.12.25

초록

목 적 : 집중 치료를 받고 있는 환자들에서 MDR-HAI이 전세계적으로 중요한 문제로 인식되고 있다. 그러나 이와 관련하여 소아 환자들을 대상으로 한 연구는 성인에 비해 상대적으로 부족하다. 본 연구에서는 단일 대학병원 중환자실에 입원한 소아환자를 대상으로 MDR-HAI의 발생률과 연관인자를 알아보고자 하였다. 방 법: 2009년 1월부터 2010년 12월까지 본원 환자실에서 3일 이상 입원치료 하였던 135명의 소아 환자를 대상으로 입원기록을 후향적으로 검토하였다. 원내감염을 MDR-HAI과 non-MDR-HAI의 두 군으로 나누어 각각 임상적 특징과 여러 연관인자들을 비교하였다. 결 과: 39명의 환자에서 45례의 중환자실내 원내감염이 발생하였다. 원내감염의 발생률은 중환자실 재원 1,000일당 47.7이었다. 45례 원내감염 중 36례(80.0%)가 다제 내성균에 의한 감염이었다. A. baumannii는 MDR-HAI군에서 더 흔하게 검출되었다(54.5% vs. 8.3%; P=0.007). 중환자실 입원 적응증 중 내과적 질환, 인공 호흡기 치료, 도뇨관 삽입, 이전 광범위 항생제 사용은 MDR-HAI군에서 통계적으로 유의하게 높았다. 회귀분석 결과 이전 광범위 항생제 사용만이 MDR-HAI의 독립적 위험인자였다. 결 론 : 중환자실내 원내감염의 발생률은 이전에 보고된 것보다 높았으며, 이전 광범위 항생제 사용이 MDR-HAI의 독립적 위험인자였다. 향후 중환자실에 입원한 소아 환자에게 발생한 MDR-HAI의 정확한 특징을 확인하기 위해 추가적인 연구가 필요할 것으로 생각된다.

Purpose : Hospital associated infection (HAI) caused by multidrug-resistant (MDR) microorganisms has been recognized as an important issue in the world, especially in critically ill patients such as the patients admitted in the intensive care unit. There are fewer papers about MDR-HAI in pediatric patients compared to adult patients. In this study, we investigated the incidence and associated factors of MDR-HAI in children admitted to the intensive care unit (ICU) of a university hospital. Methods : We retrospectively evaluated 135 children who were admitted in ICU for at least 3 days between January 2009 and December 2010. HAI cases were divided into MDR-HAI group and non-MDR-HAI group. Clinical characteristics and various associated factors were compared between those groups. Results : In 39 patients, 45 cases of ICU-related HAI were developed. ICU-related HAI incidence was 47.7 per 1000 patientdays. Thirty-six cases (80.0%) were MDR-HAI. Acinetobacter baumannii was isolated more commonly in MDR-HAI group. And the followings were found more frequently in MDR-HAI group than non-MDR-HAI group: medical condition as an indication for ICU admission, mechanical ventilation, urinary catheterization and previous use of broad-spectrum antibiotics. Among the risk factors, previous use of broad-spectrum antibiotics was the independent risk factor for MDR-HAI. Conclusion : ICU-related HAI incidence was higher than previously reported. Previous use of broad-spectrum antibiotics was the independent risk factor for MDR-HAI. To investigate the characteristics of MDR-HAI in children admitted in ICU, further studies with a larger sample size over a longer period of time are warranted.

키워드

참고문헌

  1. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059-93. https://doi.org/10.1378/chest.120.6.2059
  2. Weber DJ, Raasch R, Rutala WA. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens. Chest 1999;115:34S-41S. https://doi.org/10.1378/chest.115.suppl_1.34S
  3. Kim KM, Yoo JH, Choi JH, Park ES, Kim KS, Kim KS, et al. The nationwide sunveillance results of nosocomial infections along with antimicrobial resistance in intensive care units of sixteen university hospitals in Korea, 2004. Korean J Nosocomial Infect Control 2006;2:79-86.
  4. Erbay H, Yalcin AN, Serin S, Turgut H, Tomatir E, Cetin B, et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey. Intensive Care Med 2003;29:1482-8. https://doi.org/10.1007/s00134-003-1788-x
  5. L'Heriteau F, Alberti C, Cohen Y, Troche G, Moine P, Timsit JF. Nosocomial infection and multidrug-resistant bacteria surveillance in intensive care units: a survey in France. Infect Control Hosp Epidemiol 2005;26:13-20. https://doi.org/10.1086/502482
  6. Luzzati R, Antozzi L, Bellocco R, Del Bravo P, Mirandola M, Procaccio F, et al. Prevalence of nosocomial infections in intensive care units in Triveneto area, Italy. Minerva Anestesiol 2001;67:647-52.
  7. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995;274:639-44. https://doi.org/10.1001/jama.1995.03530080055041
  8. Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008;52:1430-7. https://doi.org/10.1128/AAC.01538-07
  9. Mireya UA, Marti PO, Xavier KV, Cristina LO, Miguel MM, Magda CM. Nosocomial infections in paediatric and neonatal intensive care units. J Infect 2007;54:212-20. https://doi.org/10.1016/j.jinf.2006.03.023
  10. Mayhall CG. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
  11. Sritippayawan S, Sri-Singh K, Prapphal N, Samransamruajkit R, Deerojanawong J. Multidrug-resistant hospital-associated infections in a pediatric intensive care unit: a cross-sectional survey in a Thai university hospital. Int J Infect Dis 2009;13:506-12. https://doi.org/10.1016/j.ijid.2008.08.022
  12. Ortega B, Groeneveld AB, Schultsz C. Endemic multidrugresistant Pseudomonas aeruginosa in critically ill patients. Infect Control Hosp Epidemiol 2004;25:825-31. https://doi.org/10.1086/502303
  13. Singh-Naz N, Sprague BM, Patel KM, Pollack MM. Risk factors for nosocomial infection in critically ill children: a prospective cohort study. Crit Care Med 1996;24:875-8. https://doi.org/10.1097/00003246-199605000-00024
  14. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9. https://doi.org/10.1001/jama.2009.1754
  15. Jeena P, Thompson E, Nchabeleng M, Sturm A. Emergence of multidrug-resistant Acinetobacter anitratus species in neonatal and pediatric intensive care units in a developing country: concern about antimicrobial policies. Ann Trop Paediatr 2001;21:245-51. https://doi.org/10.1080/02724930120077835
  16. Patra PK, Jayashree M, Singhi S, Ray P, Saxena AK. Nosocomial pneumonia in a pediatric intensive care unit. Indian Pediatr 2007;44:511-8.
  17. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007;51:3471-84. https://doi.org/10.1128/AAC.01464-06
  18. Katragkou A, Kotsiou M, Antachopoulos C, Benos A, Sofianou D, Tamiolaki M, et al. Acquisition of imipenemresistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study. Intensive Care Med 2006;32:1384-91. https://doi.org/10.1007/s00134-006-0239-x
  19. Bergogne-Berezin E. The increasing significance of outbreaks of Acinetobacter spp.: the need for control and new agents. J Hosp Infect 1995;30 Suppl:441-52. https://doi.org/10.1016/0195-6701(95)90048-9
  20. Gerner-Smidt P. Taxonomy and epidemiology of Acinetobacter infections. Rev Med Microbiol 1995;6:186-97.
  21. Garcia-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jimenez-Jimenez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med 1999;27:1794-9. https://doi.org/10.1097/00003246-199909000-00015
  22. Kuo LC, Yu CJ, Lee LN, Wang JL, Wang HC, Hsueh PR, et al. Clinical features of pandrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Taiwan. J Formos Med Assoc 2003;102:601-6.
  23. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903. https://doi.org/10.1164/ajrccm.165.7.2105078
  24. Gupta A, Agrawal A, Mehrotra S, Singh A, Malik S, Khanna A. Incidence, risk stratification, antibiogram of pathogens isolated and clinical outcome of ventilator associated pneumonia. Indian J Crit Care Med 2011;15:96-101. https://doi.org/10.4103/0972-5229.83015
  25. Srinivasan R, Asselin J, Gildengorin G, Wiener-Kronish J, Flori HR. A prospective study of ventilator-associated pneumonia in children. Pediatrics 2009;123:1108-15. https://doi.org/10.1542/peds.2008-1211
  26. D'Agata EM. Rapidly rising prevalence of nosocomial multidrug-resistant, gram-negative bacilli: a 9-year surveillance study. Infect Control Hosp Epidemiol 2004;25:842-6. https://doi.org/10.1086/502306
  27. Levy SS, Mello MJ, Gusmao-Filho FA, Correia JB. Colonisation by extended-spectrum beta-lactamase-producing Klebsiella spp. in a paediatric intensive care unit. J Hosp Infect 2010;76:66-9. https://doi.org/10.1016/j.jhin.2010.03.008
  28. Asensio A, Oliver A, Gonzalez-Diego P, Baquero F, Perez-Diaz JC, Ros P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000;30:55-60. https://doi.org/10.1086/313590
  29. Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, et al. Risk factors for an outbreak of multidrug-resistant Acinetobacter nosocomial pneumonia among intubated patients. Chest 1999;115:1378-82. https://doi.org/10.1378/chest.115.5.1378
  30. Loeffler JM, Garbino J, Lew D, Harbarth S, Rohner P. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis 2003;35:843-50. https://doi.org/10.1080/00365540310016646
  31. Lucet JC, Chevret S, Decre D, Vanjak D, Macrez A, Bedos JP, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996;22:430-6. https://doi.org/10.1093/clinids/22.3.430
  32. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998;157:531-9. https://doi.org/10.1164/ajrccm.157.2.9705064